We recently welcomed Chris Goralski from 3M for his first visit to Italy, highlighting our collaboration built on mutual respect and technical excellence.
They provide valuable technical support and product testing opportunities, while appreciating our biotech research contributions.
During the visit, CEO Luigi Aurisicchio presented our research pipeline and biotech services.
Chris Goralski and Colleen A. Lott toured our facilities, observing researchers using the Versaflo 300 safety helmets in our BSL-2 laboratory and visiting our GMP and BSL-3 facilities.
The Versaflo 300 system, acquired last year for class 3 pathogen work, demonstrates how industry partnerships deliver practical solutions for high-level biosafety operations.
This collaboration strengthens both organizations while advancing scientific research that benefits global health security.
